http://hdl.handle.net/20.500.12701/1991 The British Journal of Clinical Pharmacology is a leading international clinical pharmacology journal published by the British Pharmacological Society. Thu, 15 Feb 2024 17:41:19 GMT 2024-02-15T17:41:19Z http://hdl.handle.net/20.500.12701/1992 Название: Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia Авторы: Geers, Lisanne M.; Pozhidaev, Ivan V.; Ivanova, Svetlana A.; Freidin, Maxim B.; Schmidt, Amand F.; Cohen, Dan; Boiko, Anastasiia S.; Paderina, Diana Z.; Fedorenko, Olga Yu; Semke, Arkadiy V.; Bokhan, Nikolay A.; Wilffert, Bob; Kosterink, Jos G.W.; Touw, Daan J.; Loonen, Anton J.M. Краткий осмотр (реферат): Hyperprolactinaemia, a common adverse effect of antipsychotic drugs, is primarily linked to blockade of dopamine D2 receptors in the pituitary gland. Certain antipsychotic drugs, such as, for example risperidone and paliperidone, are more likely to induce hyperprolactinaemia compared to others. This effect is probably caused by a relatively high blood/brain concentration ratio, a consequence of being a substrate of P-glycoprotein. Genetic variants of P-glycoprotein with changed functional activity might influence the potential of risperidone and paliperidone to cause hyperprolactinaemia as the altered blood/brain concentration ratio would lead to a reduced therapeutic drug level within essential brain areas making dose adaptations necessary. This increases exposure of dopamine D2 receptors within the pituitary gland. Sat, 21 Mar 2020 00:00:00 GMT http://hdl.handle.net/20.500.12701/1992 2020-03-21T00:00:00Z